VCYT compared with TWST: revenue, margins and what each company keeps, and the suppliers and customers both name

VCYTVeracyte, Inc.

Mkt capRevenueRevenue

TWSTTwist Bioscience Corp

Mkt capRevenueRevenue

Compare

VCYTVeracyte, Inc.

TWSTTwist Bioscience Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only VCYT 9

UNHUnitedHealthcarecustomer

BRKRNanoString (now Bruker Spatial Biology as a result of Bruker Corporation's asset acquisition of NanoString)supplier

—Silicon Valley Bankunlistedsupplier

—Medicareunlistedcustomer

5 more · VCYT chain ›

Shared 0

No shared counterparties.

Only TWST 15

GRALGrailcustomer

WGSGeneDxcustomer

DNAGinkgo Bioworkscustomer

IBIOiBiocustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

11 more · TWST chain ›

VCYTVeracyte, Inc.

50.01▼−4.14%· post 49.60

Mkt cap$4.0BRevenue$150MQ2 FY26Revenue$517MFY25

TWSTTwist Bioscience Corp

153.04▼−11.77%· post 152.02

ClosedOct 30 '26

Mkt cap$9.6BRevenue$118MQ3 FY26Revenue$377MFY25

Compare

ClosedOct 30 '26

VCYTVeracyte, Inc.

TWSTTwist Bioscience Corp

50.01▼−4.14%post 49.60

Price

153.04▼−11.77%post 152.02

$4.0B

Mkt cap

$9.6B

Q2 FY26$150M

Revenue

$118MQ3 FY26

FY25$517M

Revenue

$377MFY25

VCYT50.01▼−4.14%vsTWST153.04▼−11.77%ClosedOct 30 '26